Cite
HARVARD Citation
Melmed, G. et al. (n.d.). Early remission status predicts long-term outcomes in patients with Crohn's disease treated with certolizumab pegol. Current medical research and opinion. pp. 1937-1941. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Melmed, G. et al. (n.d.). Early remission status predicts long-term outcomes in patients with Crohn's disease treated with certolizumab pegol. Current medical research and opinion. pp. 1937-1941. [Online].